Glycine for Sleep Quality

Verdict: Weak, conflicted evidence; promising but unproven

A handful of small trials hint that 3 g of glycine before bed may modestly improve subjective sleep quality and next-day alertness, but the evidence is too thin and conflicted to call it a proven sleep aid. No major health authority or clinic endorses it for sleep.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is weak (Tier C) because the entire human case rests on a small cluster of low-quality trials. In randomized studies (PMID 22293292), 3 g of glycine taken about an hour before bed improved subjective sleep quality, shortened the time to reach deep slow-wave sleep, and eased daytime sleepiness, and a double-blind trial (PMID 22529837) found less fatigue and better performance after a short night. But all of this comes from a single Japanese research group, the samples are tiny (n=11 to ~19), outcomes are mostly questionnaires, and every study was industry-funded (Ajinomoto, a glycine maker), a clear conflict of interest.

Crucially, the findings have never been replicated by a large independent trial or pooled meta-analysis, so the positive signal cannot yet be trusted as a reliable effect.

The institutional picture is unsupportive. EU regulators (EFSA) concluded that a cause-and-effect relationship has not been established and approved no sleep claim for glycine. Major clinical sources, including NIH's Office of Dietary Supplements, Mayo Clinic, Cleveland Clinic, and Harvard Health, do not list glycine as a sleep treatment, and the leading sleep-medicine guideline does not recommend it. Only the Sleep Foundation comments, cautiously noting the three small studies 'may hold promise' while flagging their limits. Bottom line: plausible and possibly helpful, but unproven, not harmful at typical doses, and not a substitute for first-line measures like CBT-I.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.45
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
80%
Highly consistent evidence
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.46
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L11 AI re-checkIndependent read
0.50
L2 PubMedPrimary literature
0.60
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.445
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep
PMID: 22293292 2012 隨機對照試驗 n = 11
Finding: Glycine attenuated daytime sleepiness and fatigue induced by acute sleep restriction; PSG signal supportive but small sample and same research group as prior studies
🟠 Limited quality ⚠️ Industry-funded
View on PubMed
New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep
PMID: 22293292 2012 RCT (open-label) n = 19
Finding: Glycine attenuated daytime sleepiness and fatigue induced by acute sleep restriction; PSG signal supportive but small sample and same research group as prior studies
🟠 Limited quality ⚠️ Industry-funded
View on PubMed
New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep
PMID: 22293292 2012 隨機對照試驗
Finding: Glycine attenuated daytime sleepiness and fatigue induced by acute sleep restriction; PSG signal supportive but small sample and same research group as prior studies
🟠 Limited quality ⚠️ Industry-funded
View on PubMed
The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers
PMID: 22529837 2012 RCT (double-blind)
Finding: Glycine reduced subjective fatigue and daytime sleepiness and improved performance on PC-based memory recognition task; consistent with prior Japanese studies but again small and same research lineage
🟠 Limited quality ⚠️ Industry-funded
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
the Food and Drug Administration no longer regards glycine and its salts as generally recognized as safe for use in human food and all outstanding letters expressing sanction for such use are rescinded. source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established source↗
L4d TW TFDA / 衛福部
Neutral
胺基乙酸 Glycine:類別 (十一) 調味劑;使用食品範圍及限量:本品可於各類食品中視實際需要適量使用;使用限制:限於食品製造或加工必須時使用。 source↗
L5e Specialty Society (condition-mapped)
Cautious
Three small human studies suggest that glycine may hold promise as a sleep aid. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-sleep-quality-INT-glycine-001 繁體中文版 →